Burning Rock Biotech Ltd (BNR) — Cash Flow-to-Debt Ratio
Latest as of March 2026:
-0.11x
Burning Rock Biotech Ltd (BNR) has a Cash Flow-to-Debt Ratio of -0.11x as of March 2026, meaning its operating cash flow of $-29.30 Million could theoretically repay 0% of its total liabilities ($271.33 Million) in one year. See Burning Rock Biotech Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.11x
Operating CF / Total Liabilities
Operating Cash Flow
$-29.30 Million
USD
Total Liabilities
$271.33 Million
USD
Data as of
Mar 2026
Most recent filing
Burning Rock Biotech Ltd Cash Flow-to-Debt Ratio (2017–2025)
Historical debt coverage capacity for Burning Rock Biotech Ltd across 9 annual periods. For the full cash flow conversion analysis, see BNR cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Burning Rock Biotech Ltd (2017–2025)
Year-by-year debt coverage analysis for Burning Rock Biotech Ltd.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.10x | $-28.44 Million | $285.29 Million | ▲ +67.1% |
| 2024 | -0.30x | $-92.26 Million | $304.48 Million | ▲ +67.8% |
| 2023 | -0.94x | $-255.78 Million | $271.59 Million | ▲ +11.5% |
| 2022 | -1.06x | $-456.81 Million | $429.13 Million | ▲ +3.5% |
| 2021 | -1.10x | $-477.89 Million | $433.28 Million | ▼ -263.0% |
| 2020 | -0.30x | $-73.54 Million | $242.02 Million | ▼ -131.7% |
| 2019 | -0.13x | $-228.04 Million | $1.74 Billion | ▲ +14.0% |
| 2018 | -0.15x | $-148.78 Million | $976.14 Million | ▲ +73.6% |
| 2017 | -0.58x | $-133.70 Million | $231.85 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.